Electronic cigarettes increase endothelial progenitor cells in the blood of healthy volunteers

Atherosclerosis

Volumn 255, Issue , 2016, Pages 179-185

  Antoniewicz, Lukasz ^a   Bosson, Jenny A ^b   Kuhl, Jeanette ^a   Abdel Halim, Samy M ^a   Kiessling, Anna ^a   Mobarrez, Fariborz ^c   Lundbäck, Magnus ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

E cigarette; Electronic cigarette; Endothelial progenitor cells; Microvesicles

Indexed keywords

CD40 LIGAND; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH MOBILITY GROUP B1 PROTEIN; NITRIC OXIDE; PADGEM PROTEIN; AUTACOID; BIOLOGICAL MARKER; COTININE; NICOTINE; NICOTINIC AGENT;

ADULT; ARTICLE; BLOOD; BLOOD SAMPLING; CONTROLLED STUDY; CROSSOVER PROCEDURE; ELECTRONIC CIGARETTE; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MEMBRANE MICROPARTICLE; MONOCYTE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; SMOKING; THROMBOCYTE; ADVERSE DEVICE EFFECT; DRUG EFFECTS; EXHALATION; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; PRODUCT SAFETY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SWEDEN; TIME FACTOR; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADULT; BIOMARKERS; CELL-DERIVED MICROPARTICLES; CONSUMER PRODUCT SAFETY; COTININE; CROSS-OVER STUDIES; ELECTRONIC CIGARETTES; ENDOTHELIAL PROGENITOR CELLS; EXHALATION; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INFLAMMATION MEDIATORS; MALE; NICOTINE; NICOTINIC AGONISTS; NITRIC OXIDE; PHENOTYPE; RISK ASSESSMENT; SWEDEN; TIME FACTORS; YOUNG ADULT;

EID: 84999791871     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.09.064     Document Type: Article

References (59)

1. [1] Morris, P.B., Ference, B.A., Jahangir, E., et al. Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: clinical perspectives from the prevention of cardiovascular disease section leadership Council and early career councils of the American college of cardiology. J. Am. Coll. Cardiol. 66 (2015), 1378–1391.
2. [2] Bhatnagar, A., Whitsel, L.P., Ribisl, K.M., et al. Electronic cigarettes: a policy statement from the american Heart association. Circulation 130 (2014), 1418–1436.
3. [3] Williams, R.S., Derrick, J., Ribisl, K.M., Electronic cigarette sales to minors via the internet. JAMA Pediatr., 169, 2015, e1563.
4. [4] Dutra, L.M., Glantz, S.A., Electronic cigarettes and conventional cigarette use among U.S. adolescents: a cross-sectional study. JAMA Pediatr. 168 (2014), 610–617.
5. [5] Manzoli, L., Flacco, M.E., Fiore, M., et al. Electronic cigarettes efficacy and safety at 12 Months: cohort study. PloS One, 10, 2015, e0129443.
6. [6] Pokhrel, P., Fagan, P., Kehl, L., et al. Receptivity to e-cigarette marketing, harm perceptions, and e-cigarette use. Am. J. Health Behav. 39 (2015), 121–131.
7. [7] McKee, M., Capewell, S., Evidence about electronic cigarettes: a foundation built on rock or sand?. Bmj, 351, 2015, h4863.
8. [8] Kavvalakis, M.P., Stivaktakis, P.D., Tzatzarakis, M.N., et al. Multicomponent analysis of replacement liquids of electronic cigarettes using chromatographic techniques. J. Anal. Toxicol. Engl., 2015, 262–269 The Author 2015. Published by Oxford University Press For Permissions, please email: journals.permissions@oup.com.
9. [9] Farsalinos, K.E., Gillman, I.G., Melvin, M.S., et al. Nicotine levels and presence of selected tobacco-derived toxins in tobacco flavoured electronic cigarette refill liquids. Int. J. Environ. Res. Public Health Switz., 2015, 3439–3452.
10. [10] Goniewicz, M.L., Kuma, T., Gawron, M., et al. Nicotine levels in electronic cigarettes. Nicotine Tob. Res. 15 (2013), 158–166.
11. [11] Williams, M., Villarreal, A., Bozhilov, K., et al. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PloS One, 8, 2013, e57987.
12. [12] Kosmider, L., Sobczak, A., Fik, M., et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob. Res., 2014, 1319–1326 England, The Author 2014. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco For permissions, please e-mail: journals.permissions@oup.com.
13. [13] Lerner, C.A., Sundar, I.K., Yao, H., et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PloS One, 10, 2015, e0116732.
14. [14] Geiss, O., Bianchi, I., Barahona, F., et al. Characterisation of mainstream and passive vapours emitted by selected electronic cigarettes. Int. J. Hyg. Environ. Health 218 (2015), 169–180.
15. [15] Schweitzer, K.S., Chen, S.X., Law, S., et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am. J. Physiol. Lung Cell Mol. Physiol. 309 (2015), L175–L187.
16. [16] Hibbert, B., Olsen, S., O'Brien, E., Involvement of progenitor cells in vascular repair. Trends Cardiovasc. Med. 13 (2003), 322–326.
17. [17] Lekakis, J., Abraham, P., Balbarini, A., et al. Methods for evaluating endothelial function: a position statement from the european society of cardiology working group on peripheral circulation. Eur. J. Cardiovasc Prev. Rehabil. 18 (2011), 775–789.
18. [18] Martinez, M.C., Tual-Chalot, S., Leonetti, D., et al. Microparticles: targets and tools in cardiovascular disease. Trends Pharmacol. Sci. 32 (2011), 659–665.
19. [19] Newby, D.E., Wright, R.A., Labinjoh, C., et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation 99 (1999), 1411–1415.
20. [20] Mobarrez, F., Antoniewicz, L., Bosson, J.A., et al. The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteers. PloS One, 9, 2014, e90314.
21. [21] Flouris, A.D., Chorti, M.S., Poulianiti, K.P., et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal. Toxicol. 25 (2013), 91–101.
22. [22] Dweik, R.A., Boggs, P.B., Erzurum, S.C., et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am. J. Respir. Crit. Care Med. 184 (2011), 602–615.
23. [23] Faul, F., Erdfelder, E., Lang, A.G., et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39 (2007), 175–191.
24. [24] Liu, Z., Ding, X., Fang, F., et al. Higher numbers of circulating endothelial progenitor cells in stroke patients with intracranial arterial stenosis. BMC Neurol., 13, 2013, 161.
25. [25] Regueiro, A., Cuadrado-Godia, E., Bueno-Beti, C., et al. Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: time-course after acute myocardial infarction and stroke. J. Mol. Cell Cardiol. 80 (2015), 146–155.
26. [26] Torsney, E., Xu, Q., Resident vascular progenitor cells. J. Mol. Cell Cardiol. 50 (2011), 304–311.
27. [27] Kawasaki, T., Nishiwaki, T., Sekine, A., et al. Vascular repair by tissue-resident endothelial progenitor cells in endotoxin-induced lung injury. Am. J. Respir. Cell Mol. Biol. 53 (2015), 500–512.
28. [28] Rodriguez-Carrio, J., Prado, C., de Paz, B., et al. Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients. Rheumatology 51 (2012), 1775–1784.
29. [29] Grisar, J., Aletaha, D., Steiner, C.W., et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 111 (2005), 204–211.
30. [30] Padfield, G.J., Tura, O., Haeck, M.L., et al. Circulating endothelial progenitor cells are not affected by acute systemic inflammation, American journal of physiology. Heart Circulatory Physiol. 298 (2010), H2054–H2061.
31. [31] Wang, X., Zhu, J., Chen, J., et al. Effects of nicotine on the number and activity of circulating endothelial progenitor cells. J. Clin. Pharmacol. 44 (2004), 881–889.
32. [32] Zhu, B.Q., Heeschen, C., Sievers, R.E., et al. Second hand smoke stimulates tumor angiogenesis and growth. Cancer Cell 4 (2003), 191–196.
33. [33] Sugimoto, A., Masuda, H., Eguchi, M., et al. Nicotine enlivenment of blood flow recovery following endothelial progenitor cell transplantation into ischemic hindlimb. Stem Cells Dev. 16 (2007), 649–656.
34. [34] Kondo, T., Hayashi, M., Takeshita, K., et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler. Thromb. Vasc. Biol. 24 (2004), 1442–1447.
35. [35] Czogala, J., Goniewicz, M.L., Fidelus, B., et al. Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob. Res. 16 (2014), 655–662.
36. [36] Lerner, C.A., Sundar, I.K., Watson, R.M., et al. Environmental health hazards of e-cigarettes and their components: oxidants and copper in e-cigarette aerosols. Environ. Pollut. 198 (2015), 100–107 (Barking, Essex: 1987).
37. [37] Newby, D.E., Mannucci, P.M., Tell, G.S., et al. Expert position paper on air pollution and cardiovascular disease. Eur. Heart J. 36 (2015), 83b–93b.
38. [38] Talhout, R., Schulz, T., Florek, E., et al. Hazardous compounds in tobacco smoke. Int. J. Environ. Res. Public Health 8 (2011), 613–628.
39. [39] Brook, R.D., Cardiovascular effects of air pollution. Clin. Sci. (Lond) 115 (2008), 175–187.
40. [40] Papoušek, R., Pataj, Z., Nováková, P., et al. Determination of acrylamide and acrolein in smoke from tobacco and e-cigarettes. Chromatographia 77 (2014), 1145–1151.
41. [41] Herrington, J.S., Myers, C., Electronic cigarette solutions and resultant aerosol profiles. J. Chromatogr. A 1418 (2015), 192–199.
42. [42] Farsalinos, K.E., Voudris, V., Poulas, K., E-cigarettes generate high levels of aldehydes only in 'dry puff' conditions. Addiction 110 (2015), 1352–1356.
43. [43] Zhang, Y., Sumner, W., Chen, D.R., In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob. Res. 15 (2013), 501–508.
44. [44] Nemmar, A., Hoet, P.H., Vanquickenborne, B., et al. Passage of inhaled particles into the blood circulation in humans. Circulation 105 (2002), 411–414.
45. [45] Brook, R.D., Bard, R.L., Kaplan, M.J., et al. The effect of acute exposure to coarse particulate matter air pollution in a rural location on circulating endothelial progenitor cells: results from a randomized controlled study. Inhal. Toxicol. 25 (2013), 587–592.
46. [46] O'Toole, T.E., Hellmann, J., Wheat, L., et al. Episodic exposure to fine particulate air pollution decreases circulating levels of endothelial progenitor cells. Circulation Res. 107 (2010), 200–203.
47. [47] Varlet, V., Farsalinos, K., Augsburger, M., et al. Toxicity assessment of refill liquids for electronic cigarettes. Int. J. Environ. Res. public health 12 (2015), 4796–4815.
48. [48] Williams, J.K., Baptista, P.M., Daunais, J.B., et al. The effects of ethanol consumption on vasculogenesis potential in nonhuman primates. Alcohol Clin. Exp. Res. 32 (2008), 155–161.
49. [49] Huang, P.H., Chen, Y.H., Tsai, H.Y., et al. Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 869–877.
50. [50] Dawkins, L., Turner, J., Roberts, A., et al. 'Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction 108 (2013), 1115–1125.
51. [51] Gallagher, K.A., Liu, Z.J., Xiao, M., et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J. Clin. Invest. 117 (2007), 1249–1259.
52. [52] Schniedermann, J., Rennecke, M., Buttler, K., et al. Mouse lung contains endothelial progenitors with high capacity to form blood and lymphatic vessels. BMC Cell Biol., 11, 2010, 50.
53. [53] Madden, L.A., Vince, R.V., Sandstrom, M.E., et al. Microparticle-associated vascular adhesion molecule-1 and tissue factor follow a circadian rhythm in healthy human subjects. Thrombosis Haemostasis 99 (2008), 909–915.
54. [54] Christersson, C., Lindahl, B., Siegbahn, A., The composition and daily variation of microparticles in whole blood in stable coronary artery disease. Scand. J. Clin. Labor. Investig. 76 (2016), 25–32.
55. [55] Heiss, C., Amabile, N., Lee, A.C., et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J. Am. Coll. Cardiol. 51 (2008), 1760–1771.
56. [56] Szponar, B., Pehrson, C., Larsson, L., Bacterial and fungal markers in tobacco smoke. Sci. Total Environ. 438 (2012), 447–451.
57. [57] Soop, A., Hallstrom, L., Frostell, C., et al. Effect of lipopolysaccharide administration on the number, phenotype and content of nuclear molecules in blood microparticles of normal human subjects. Scand. J. Immunol. 78 (2013), 205–213.
58. [58] Zubair, A.C., Malik, S., Paulsen, A., et al. Evaluation of mobilized peripheral blood CD34(+) cells from patients with severe coronary artery disease as a source of endothelial progenitor cells. Cytotherapy 12 (2010), 178–189.
59. [59] Alvarez, D.F., Huang, L., King, J.A., et al. Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity. Am. J. Physiology-Lung Cell. Mol. Physiology 294 (2008), L419–L430.